Investor Krensavage Asset Management, LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Krensavage Asset Management, LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-02-27 13G ENTA / Enanta Pharmaceuticals, Inc. 1,055,719 1,086,024
2021-02-19 13G/A SRGA / Surgalign Holdings Inc 6,423,408
2019-02-14 13G US74975N1054 / RTI Surgical, Inc. 4,438,950 4,443,771
2018-02-15 13G VXRT / Vaxart, Inc. 2,809,531
2017-03-16 13D/A US74975N1054 / RTI Surgical, Inc. 4,216,948 4,438,950
2017-02-17 13D/A US74975N1054 / RTI Surgical, Inc. 4,054,764 4,216,948
2017-02-15 13G ENTA / Enanta Pharmaceuticals, Inc. 1,055,719
2017-02-14 13G VXRT / Vaxart, Inc. 2,737,602
2017-02-14 13G VXRT / Vaxart, Inc. 2,625,239 2,737,602
2016-07-28 13D/A US74975N1054 / RTI Surgical, Inc. 3,500,795 4,054,764
2016-05-31 13D/A US74975N1054 / RTI Surgical, Inc. 3,447,090 3,500,795
2016-04-14 13D/A US74975N1054 / RTI Surgical, Inc. 3,447,090 3,447,090
2016-02-23 13D/A US74975N1054 / RTI Surgical, Inc. 3,076,929 3,447,090
2016-02-17 13G/A VXRT / Vaxart, Inc. 2,625,239
2015-11-09 13D US74975N1054 / RTI Surgical, Inc. 3,076,929